Scholars Central

Research articlePublished 3 May 2019

Evaluation of aspirin resistance in elderly people in rural population in India.

Authors: Jyothsna Kudaravalli, Narayan Deshpande, Srinivas Rao Avanapu, G.Vijaya Lakshmi, Nagaveni

Der Pharmacia Lettre

Volume 3 · Issue 2 · Pages 5–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Lowdose aspirin remains the gold standard therapy in the prevention of myocardial infarction, ischaemic stroke, and vascular death among patients at high and low risk of these events. . In aspirin ‘resistance’ the change is not in the drug target, and the effects can fluctuate over time and are at least partly reversible by increasing the dose. Biochemical Endpoints for in Vivo and ex Vivo Tests were done. Aspirin dose 325 to 1,300 mg daily were administered to previous ischaemic stoke patients to investigate the extent of inhibition of platelet aggregation. Signaldependent de novo synthesis of COX1 occuring over time in aspirin-treated platelets after persistent activation has been suggested to provide an additional source of aspirin-insensitive thromboxane biosynthesis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharmacia Lettre.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharmacia Lettre
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jyothsna Kudaravalli”
  • BylineArticles whose byline prints “Narayan Deshpande”
  • BylineArticles whose byline prints “Srinivas Rao Avanapu”
  • BylineArticles whose byline prints “G.Vijaya Lakshmi”
  • BylineArticles whose byline prints “Nagaveni”